Enanta Pharmaceuticals, Inc.

NASDAQ:ENTA

5.63 (USD) • At close April 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220112010
Operating Activities:
Net Income -116.045-133.816-121.755-78.996-36.16846.38371.95617.7121.66678.99234.4389.62721.39923.317.904
Depreciation & Amortization 2.3362.3712.9733.3343.6443.2582.5182.1371.6610.6390.3520.2210.1720.4990.553
Deferred Income Tax 0-10.55300.34510.608-3.1381.858-1.654-2.29411.028-15.2110.7810-0.360
Stock Based Compensation 26.79528.21626.96920.99119.57519.22615.84513.0719.3545.8382.6821.0630.4240.2250.259
Change In Working Capital 7.138.0246.789-13.68812.911.491-61.78721.976.171-16.83-2.2580.7410.093-2.4-18.411
Accounts Receivables 0.9739.4183.258-0.08427.82115.892-56.5912.2272.448-13.565-0.9160.241-0.788-0.251-0.006
Inventory 0000-16.3-6.483-6.42118.6321.875-3.371-1.7310.370.096-1.3931.555
Accounts Payables -0.414-1.151-4.6343.774-0.8831.7911.3170.6331.451-0.5430.3990.1150.7630.0580.181
Other Working Capital 6.571-0.2438.165-17.3782.2620.291-0.0920.4780.3970.649-0.010.0150.022-0.814-20.141
Other Non Cash Items 1.022.6040.242-1.982-3.471-5.802-1.17-0.581-0.749-2.9940.176-1.780.5352.745-0.48
Operating Cash Flow -78.764-103.154-84.782-69.9967.08871.41829.2252.65335.80976.67320.17910.65322.62324.019-10.175
Investing Activities:
Investments In Property Plant And Equipment -17.948-9.058-2.125-0.75-1.445-5.417-2.981-2.506-4.738-2.336-1.028-0.606-0.252-0.445-0.037
Acquisitions Net 044.52-54.897-37.741-21.27586.6640000.009000.0660.0090
Purchases Of Investments -307.282-373.391-171.446-307.348-338.553-549.312-293.103-251.371-192.429-196.304-98.405-115.888-47.694-33.574-0.603
Sales Maturities Of Investments 383.465328.871228.468345.089359.828468.065260.682249.305153.504110.61799.92747.27828.716.7642.303
Other Investing Activites 0-44.5254.89737.74121.275-86.664-32.421-2.066-38.925-0.1720.003-68.611.14-0.4360
Investing Cash Flow 58.235-53.57854.89736.99119.83-86.664-35.402-4.572-43.663-88.1860.497-69.216-18.04-17.6821.663
Financing Activities:
Debt Repayment -27.4790000-0.086-0.079-0.073-0.06800000-0.007
Common Stock Issued 02.20821.2623.61410.4816.8486.2441.0791.7470059.892000
Common Stock Repurchased 00-1.229-0.534-1.498-4.188-1.756-0.2020000000
Dividends Paid 000000000000000
Other Financing Activities -0.147198.12620.0333.088.9832.664.4881.092.7732.541.164-2.981-0.9090.0340.015
Financing Cash Flow -27.626198.12620.0333.088.9832.5744.4091.0172.7052.541.16456.911-0.9090.0340.008
Other Information:
Effect Of Forex Changes On Cash 000000000000000
Net Change In Cash -48.15541.394-9.852-29.92535.901-12.672-1.77349.098-5.149-8.97321.84-1.6523.6746.371-8.504
Cash At End Of Period 41.20189.35647.96257.81487.73951.83863.90265.67516.57721.72630.6998.85910.5116.8370.466